Malignant Extragonadal Nongerminomatous Germ Cell Tumor

Malignant Extragonadal Nongerminomatous Germ Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 2
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Children's Oncology Group
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03067181	Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors	recruiting	Phase 3	1,780	Children's Oncology GroupNETWORK	9	Aug 25, 2026	clinicaltrials

Data updated 22 days agoSource updated Aug 25, 2026source: clinicaltrials